The Ordinary

The Ordinary is a Canadian skincare brand established in 2016 as part of DECIEM, the beauty company founded by Brandon Truaxe. It became known for presenting skincare through recognizable active ingredients rather than through highly stylized product names or prestige-brand storytelling. Its early range included single-ingredient and relatively simple formulations based on substances such as retinoids, vitamin C, niacinamide, hyaluronic acid, alpha hydroxy acids, beta hydroxy acids, and exfoliating acids. This format made the products comparatively easy for consumers to compare, while also requiring users to understand concentration, compatibility, application order, and sun protection. The brand's central commercial proposition has been to offer functional skincare at prices substantially below those associated with many prestige competitors. The Ordinary's packaging, product naming, and online communications reinforce this proposition: products generally identify their principal active ingredients and concentrations, and the visual system is restrained, clinical, and largely free of luxury cues. The approach helped turn ingredient literacy into a mass-market beauty trend. It also positioned the brand between traditional drugstore skincare and higher-priced clinical or dermatological brands. The Ordinary was created within DECIEM's multi-brand portfolio and initially benefited from the parent company's experimental, digitally oriented operating model. Its rapid growth was driven by social media discussion, beauty-community reviews, online retail, and word-of-mouth rather than by a conventional global advertising campaign. The brand later expanded through its own e-commerce channels, selected retail partners, and branded stores. Its portfolio has broadened beyond basic serums to include cleansers, moisturizers, sunscreens in some markets, toners, masks, hair and scalp products, and other treatment categories, while retaining an emphasis on recognizable ingredients and relatively accessible pricing. The Estée Lauder Companies first invested in DECIEM in 2017 and increased its ownership over time. The relationship gave DECIEM and The Ordinary access to greater international distribution and corporate resources while allowing the brand to retain much of its distinctive identity. The Ordinary remains closely associated with DECIEM, and its public-facing proposition continues to emphasize transparency, affordability, and ingredient education. The brand has also faced the practical challenges that accompany simplified ingredient-led marketing. Some products contain high concentrations of active ingredients that may irritate skin or be unsuitable for particular users when combined incorrectly. The Ordinary has therefore increasingly emphasized routine guidance, usage instructions, patch testing, and professional advice where appropriate. Its significance in beauty lies not only in its product sales but also in its role in normalizing ingredient-based comparison, concentration disclosure, and price scrutiny across the skincare market.

The Ordinary emerged from DECIEM, a Toronto-based beauty company founded by Brandon Truaxe in 2013. DECIEM described itself as a multi-brand platform and developed products intended to challenge conventional beauty pricing, distribution, and marketing. The Ordinary was introduced in 2016 and quickly became the most internationally visible brand in the portfolio. Its early identity was built around a deliberately plain presentation. Product names commonly foregrounded an active ingredient and its concentration, while bottles and cartons used a laboratory-inspired visual language. Rather than asking consumers to buy into a proprietary luxury narrative, the brand encouraged them to compare ingredients and prices. This made products such as niacinamide treatments, hyaluronic acid serums, retinoids, vitamin C formulas, and acid exfoliants highly legible in online discussions. The model appealed to consumers who wanted affordable alternatives to expensive active-skincare products and to a growing audience interested in cosmetic chemistry. Beauty influencers, online reviewers, and social platforms amplified the range, often turning individual products into viral recommendations. The brand's direct-to-consumer presence and selective retail expansion helped it grow internationally while preserving a relatively austere, clinical image. The Ordinary's growth occurred alongside increasing consumer interest in ingredient transparency. Its approach contributed to a broader shift in skincare marketing, with competing brands placing greater emphasis on active ingredients, concentration disclosure, routine education, and price comparison. At the same time, the brand's formulas demonstrated the limits of reducing skincare decisions to a single ingredient. High-strength acids and retinoid products can cause irritation, and combining incompatible actives can be problematic. The company consequently developed more extensive guidance around product use and routines. DECIEM's corporate history became complicated by conflict surrounding founder Brandon Truaxe. In 2018, public statements and management disputes culminated in a temporary closure of operations and changes in leadership. Truaxe died in 2019, after which Nicola Kilner became the company's principal public-facing executive. The Estée Lauder Companies had invested in DECIEM in 2017 and announced an agreement in 2021 to purchase the remaining interest. The transaction strengthened DECIEM's resources and international reach while The Ordinary continued to operate with its own brand identity. The current brand portfolio extends beyond its original serum-led assortment. It includes cleansers, moisturizers, exfoliating treatments, masks, toners, eye-area products, retinoid products, and hair and scalp care. Product availability varies by market, particularly for sunscreen and certain regulated ingredients. The Ordinary remains defined by accessible pricing, ingredient-forward naming, direct communication, and a visual system that contrasts with traditional prestige cosmetics.

• 2021

  Estée Lauder agrees to acquire remaining DECIEM interest

  [4]The Estée Lauder Companies to acquire the remaining interest in DECIEMelcompanies.com

  Estée Lauder announces an agreement to acquire the remaining ownership interest in DECIEM.

• 2019

  Founder Brandon Truaxe dies

  [6]Founder Brandon Truaxe diestheguardian.com

  Brandon Truaxe dies in Toronto; Nicola Kilner subsequently leads DECIEM.

• 2018

  DECIEM undergoes leadership turmoil

  [5]DECIEM and The Ordinary leadership reportingtheguardian.com

  A public dispute involving founder Brandon Truaxe leads to a temporary operational closure and leadership changes.

• 2017

  Estée Lauder takes a minority stake in DECIEM

  [3]The Estée Lauder Companies invests in DECIEMelcompanies.com

  The Estée Lauder Companies invests in DECIEM, supporting the group's international development.

• 2016

  The Ordinary launches

  [1]The Ordinary official websitetheordinary.com

  The Ordinary enters the market with ingredient-focused skincare presented at accessible prices.

• 2013

  DECIEM is founded

  [2]DECIEM official websitedeciem.com

  Brandon Truaxe establishes DECIEM in Toronto as a multi-brand beauty company.

Ingredient-led, transparent, accessible skincare positioned between mass-market and prestige beauty. The brand emphasizes named active ingredients, disclosed concentrations, restrained packaging, educational communication, and comparatively low prices.

• Facial serum

  Niacinamide 10% + Zinc 1%

  A water-based treatment centered on niacinamide and zinc PCA. It is marketed for concerns including the appearance of blemishes, excess sebum, and uneven-looking skin. Its ingredient-forward name and low price helped make it one of the brand's most recognizable products.

• Hydrating serum

  Hyaluronic Acid 2% + B5

  A hydrating serum using multiple forms of hyaluronic acid together with vitamin B5. It is designed to support surface hydration and is commonly used as a water-based step before moisturizer.

• Exfoliating treatment

  AHA 30% + BHA 2% Peeling Solution

  A short-contact exfoliating mask combining alpha hydroxy acids and beta hydroxy acid. The product became widely associated with The Ordinary's high-strength, low-cost treatment positioning and requires careful adherence to usage and sun-protection guidance.

• Exfoliating toner

  Glycolic Acid 7% Exfoliating Toner

  A glycolic-acid toner intended to improve the appearance of texture and dullness. It represents the brand's expansion from small treatment serums into larger-format routine products.

• Moisturizer

  Natural Moisturizing Factors + HA

  A daily moisturizer formulated around components associated with the skin's natural moisturizing factors, supplemented with hyaluronic acid. It gives the brand a basic barrier-supporting product alongside its more targeted actives.

• Eye-area serum

  Caffeine Solution 5% + EGCG

  A lightweight eye-area treatment featuring caffeine and EGCG from green tea. It is marketed for the appearance of puffiness and pigmentation around the eyes, subject to the limitations of topical skincare claims.

• 2020

  Priceline recalls potentially counterfeit The Ordinary products

  Priceline Pharmacy issued a recall after four Sydney franchise stores were found selling counterfeit versions of The Ordinary skincare products. Priceline directed the stores to remove the products, began an investigation, and recommended that customers who bought potentially counterfeit products stop using them and return them for a full refund.

  Source

Read more

• 2021

  Agreement to acquire the remaining interest in DECIEMM&A

  Background

  Following its earlier investment, Estée Lauder sought full ownership of the fast-growing DECIEM group.

  Action taken

  Estée Lauder announced an agreement to acquire the remaining ownership interest in DECIEM.

  Aftermath

  The transaction made DECIEM part of Estée Lauder's wholly owned brand portfolio and supported further global development of The Ordinary.

  Source

• 2017

  Accepting Estée Lauder's minority investmentM&A

  Background

  DECIEM and The Ordinary were expanding rapidly and required greater resources for international growth and distribution.

  Action taken

  The Estée Lauder Companies acquired a minority stake in DECIEM.

  Aftermath

  The investment connected DECIEM with a global prestige-beauty group while the brands continued operating under their existing identities.

  Source

• 2020.09.11

  Reported2020.09.11

  Priceline responds to counterfeit The Ordinary product sales[8]Priceline recalls potentially counterfeit The Ordinary productsdailymail.com

  Priceline issued a warning and apology after counterfeit The Ordinary skincare products were sold. The products were removed from four stores, and Priceline said an investigation into how the items were improperly sourced and sold was underway.

• 2020.09.11

  Reported2020.09.11

  Priceline recalls potentially counterfeit The Ordinary products[7]Priceline recalls potentially counterfeit The Ordinary productspedestrian.tv

  Priceline Pharmacy issued a recall after four Sydney franchise stores were found selling counterfeit versions of The Ordinary skincare products. Priceline directed the stores to remove the products, began an investigation, and recommended that customers who bought potentially counterfeit products stop using them and return them for a full refund.

Read more

1. 1The Ordinary official websitetheordinary.com
2. 2DECIEM official websitedeciem.com
3. 3The Estée Lauder Companies invests in DECIEMelcompanies.com
4. 4The Estée Lauder Companies to acquire the remaining interest in DECIEMelcompanies.com
5. 5DECIEM and The Ordinary leadership reportingtheguardian.com
6. 6Founder Brandon Truaxe diestheguardian.com
7. 7Priceline recalls potentially counterfeit The Ordinary productspedestrian.tv
8. 8Priceline recalls potentially counterfeit The Ordinary productsdailymail.com